TABLE 5.
Characteristic | N | Events | Median Overall Survival Time (months) |
Two–Year Overall Survival Rate (%) |
p-value |
---|---|---|---|---|---|
Overall Survival | 71 | 50 | 20.1 | 42.5 | |
Age at Diagnosis | |||||
Age < 50 | 19 | 15 | 17.4 | 28.9 | 0.38 |
Age ≥ 50 | 52 | 35 | 24.1 | 47.3 | |
Sex | |||||
Male | 39 | 27 | 21.2 | 42.7 | 0.23 |
Female | 32 | 23 | 21.0 | 45.5 | |
T Stage | |||||
T1 | 0 | -- | -- | -- | 0.17 |
T2 | 4 | 4 | 12.5 | 25.0 | |
T3 | 20 | 15 | 12.4 | 34.1 | |
T4 | 25 | 18 | 22.5 | 43.7 | |
N Stage | |||||
N0 | 3 | 3 | 12.4 | 0 | 0.34 |
N1 | 14 | 10 | 34.5 | 71.4 | |
N2 | 31 | 23 | 17.4 | 25.6 | |
Site of Primary Tumor | |||||
Right | 41 | 28 | 21.0 | 41.0 | 0.88 |
Left | 15 | 11 | 24.6 | 53.6 | |
Rectal | 15 | 11 | 17.8 | 37.5 | |
BRAF Mutation | |||||
Type | |||||
V600E | 67 | 47 | 20.0 | 40.0 | 0.04 |
D594G | 4 | 3 | 47.2 | 100.0 |